These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1699833)

  • 21. Cysteamine exerts multiple effects on the endocrine cells of the rat pancreas.
    Ostenson CG; Efendić S
    Biochim Biophys Acta; 1985 Aug; 846(2):242-7. PubMed ID: 2862920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
    Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin type A receptors mediate intestinal fat-induced inhibition of acid secretion through somatostatin-14 in dogs.
    Fung L; Pokol-Daniel S; Greenberg GR
    Endocrinology; 1994 Jun; 134(6):2376-82. PubMed ID: 7910794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cholecystokinin in the inhibition of gastric acid secretion in dogs.
    Konturek SJ; Bilski J; Tasler J; Cieszkowski M
    J Physiol; 1992; 451():477-89. PubMed ID: 1403819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity.
    McIntosh CH; Bakich V; Bokenfohr K; DiScala-Guenot D; Kwok YN; Brown JC
    Regul Pept; 1988 Jun; 21(3-4):205-18. PubMed ID: 2901134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the duodenal ulcerogen cysteamine on somatostatin and gastrin cells in the rat.
    Seiler M; Szabo S; Ourieff S; McComb DJ; Kovacs K; Reichlin S
    Exp Mol Pathol; 1983 Oct; 39(2):207-18. PubMed ID: 6137403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.
    Silvestre RA; Miralles P; Moreno P; Villanueva ML; Marco J
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1291-7. PubMed ID: 2868720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of islet hormones on amylase secretion and localization of somatostatin binding sites.
    Garry DJ; Garry MG; Williams JA; Mahoney WC; Sorenson RL
    Am J Physiol; 1989 May; 256(5 Pt 1):G897-904. PubMed ID: 2470260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteamine blocks somatostatin secretion without altering the course of insulin or glucagon release. A new model for the study of islet function.
    Sorenson RL; Grouse LH; Elde RP
    Diabetes; 1983 Apr; 32(4):377-9. PubMed ID: 6131850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers.
    Fukuhara S; Suzuki H; Masaoka T; Arakawa M; Hosoda H; Minegishi Y; Kangawa K; Ishii H; Kitajima M; Hibi T
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G138-45. PubMed ID: 15778430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cysteamine on bile secretion in the rat.
    Abdel Salam OM; Baiuomy AR; El-Shenawy SM
    Pharmacol Rep; 2005; 57(3):345-51. PubMed ID: 15985717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the action of the novel cholecystokinin-releasing peptide diazepam binding inhibitor by inhibitory hormones and taurocholate.
    Herzig KH; Wilgus C; Schön I; Tatemoto K; Fölsch UR
    Regul Pept; 1998 Jun; 74(2-3):193-8. PubMed ID: 9712181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of cysteamine on the Brunner gland secretion in the rat.
    Kirkegaard P; Poulsen SS; Halse C; Loud FB; Skov Olsen P; Christiansen J
    Scand J Gastroenterol; 1981; 16(1):93-6. PubMed ID: 7233083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat.
    Lewis LD; Williams JA
    Am J Physiol; 1990 Apr; 258(4 Pt 1):G512-8. PubMed ID: 1970707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteamine can induce duodenal ulceration in rats without depletion of immunoreactive somatostatin.
    Kapuscinski M; Shulkes A; Green M; Read D; MacLellan DG
    Regul Pept; 1991 Nov; 36(3):391-406. PubMed ID: 1687422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is somatostatin a true local inhibitory regulator of insulin secretion?
    Kanatsuka A; Makino H; Osegawa M; Kasanuki J; Suzuki T; Yoshida S; Horie H
    Diabetes; 1984 Jun; 33(6):510-5. PubMed ID: 6202577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of cysteamine and propionitrile on duodenal phosphoprotein phosphatase in rats.
    Japundzić I; Japundzić M; Levi E; Szabo S
    Arch Biochem Biophys; 1988 Aug; 264(2):525-32. PubMed ID: 2899991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors.
    Srikant CB; Patel YC
    Endocrinology; 1984 Sep; 115(3):990-5. PubMed ID: 6146517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pantethine, a cysteamine precursor, depletes immunoreactive somatostatin and prolactin in the rat.
    Reichlin S; Bollinger-Gruber JA
    Endocrinology; 1985 Aug; 117(2):492-5. PubMed ID: 2862009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of gastrin to cysteamine-induced gastric acid secretion in rats.
    van de Brug FJ; Jansen JB; Kuijpers IJ; Lamers CB
    Life Sci; 1993; 52(23):1861-7. PubMed ID: 8502123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.